These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12147020)

  • 1. Four-year survival of transfusion recipients identified by hepatitis C lookback.
    Vamvakas EC; Goldstein R
    Transfusion; 2002 Jun; 42(6):691-7. PubMed ID: 12147020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probability of receiving testing in a national lookback program: the English HCV experience.
    Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
    Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses and sources of data on long-term survival after blood transfusion.
    Vamvakas EC
    Transfus Med Rev; 2003 Jul; 17(3):194-208. PubMed ID: 12881780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Orebro County, Sweden.
    Tynell E; Norda R; Montgomery SM; Björkman A
    Vox Sang; 2005 Apr; 88(3):181-8. PubMed ID: 15787728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pilot study of the characteristics of transfused patients and utilized labile blood products].
    Mathoulin-Pélissier S; Vicariot M; Gross S; Waller C; Courtois F; Eghbali H; Saves M; Verret C; Salmi LR
    Transfus Clin Biol; 1997 Dec; 4(6):533-40. PubMed ID: 9527418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after blood transfusion: a population based study in the North of England.
    Wallis JP; Wells AW; Matthews JN; Chapman CE
    Transfusion; 2004 Jul; 44(7):1025-32. PubMed ID: 15225243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Length of survival after perioperative transfusion.
    Vamvakas EC; Moore SB
    Transfus Med; 1997 Jun; 7(2):115-21. PubMed ID: 9195697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in transfusion recipients in Sweden, 1993.
    Tynell E; Norda R; Shanwell A; Björkman A
    Transfusion; 2001 Feb; 41(2):251-5. PubMed ID: 11239231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after transfusion as assessed in a large multistate US cohort.
    Kleinman S; Marshall D; AuBuchon J; Patton M
    Transfusion; 2004 Mar; 44(3):386-90. PubMed ID: 14996196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of blood component use in a German university hospital.
    Zimmermann R; Büscher M; Linhardt C; Handtrack D; Zingsem J; Weisbach V; Eckstein R
    Transfusion; 1997 Oct; 37(10):1075-83. PubMed ID: 9354829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post transfusion hepatitis: comparison between homologous and autologous blood transfusion.
    Meraviglia P; Viganï P; Gubertini G; Santoli E; Santoli C; Cargnel A
    Eur J Med; 1992 May; 1(2):75-9. PubMed ID: 1342376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
    Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
    Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood transfusion utilization and recipient survival at Hospital das Clinicas in São Paulo, Brazil.
    Goncalez TT; Sabino EC; Capuani L; Liu J; Wright DJ; Walsh JH; Ferreira JE; Chamone DA; Busch MP; Custer B;
    Transfusion; 2012 Apr; 52(4):729-38. PubMed ID: 22593845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
    Christensen PB; Groenbaek K; Krarup HB
    Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after blood transfusion.
    Kamper-Jørgensen M; Ahlgren M; Rostgaard K; Melbye M; Edgren G; Nyrén O; Reilly M; Norda R; Titlestad K; Tynell E; Hjalgrim H
    Transfusion; 2008 Dec; 48(12):2577-84. PubMed ID: 18673342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV lookback in the United States: effectiveness of an extended lookback program.
    Menozzi D; Udulutch T; Llosa AE; Galel SA
    Transfusion; 2000 Nov; 40(11):1393-8. PubMed ID: 11099671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.
    Yawn BP; Wollan P; Gazzuola L; Kim WR
    J Fam Pract; 2002 Feb; 51(2):135-40. PubMed ID: 11978211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.